MCTS1 Antikörper (N-Term)
-
- Target Alle MCTS1 Antikörper anzeigen
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MCTS1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to MCTS1.
- Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
- Immunogen
- KLH conjugated synthetic peptide selected from the N-terminal region of human MCTS1
- Top Product
- Discover our top product MCTS1 Primärantikörper
-
-
- Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
- Andere Bezeichnung
- MCTS1 (MCTS1 Produkte)
- Hintergrund
- MCTS1 play a role in cell cycle regulation, decreases cell doubling time and anchorage-dependent growth, shortens the duration of G1 transit time and G1/S transition.Synonyms: MCT-1, MCT1, MCTS1, Malignant T cell amplified sequence 1
- Gen-ID
- 28985
- NCBI Accession
- NP_054779
- UniProt
- Q9ULC4
-